SUMMARY Chylous ascites has rarely been reported in yellow nail syndrome. A case of chylous ascites in yellow nail syndrome is described which was treated successfully with dietary restriction of fat and supplements of medium chained triglycerides. Samman Investigations showed a normal haemoglobin level of 12.8 g/dl, leucocytosis of 14x 10/I" (85% neutrophils), thrombocytosis of 828x 10/I, and and ESR of 102 mm in one hour. Biochemical profile revealed abnormal liver function tests; albumin reduced at 28 g/l, normal total protein of 64 g/l, AST and alkaline phosphatase were both raised at 91 lU/1 and 270 lU/1 respectively. Screenings for viral hepatitis, autoimmune antibodies and faecal occult blood were negative. Immunoglobulins and thyroid function test were with normal range. Rheumatoid factor was positive at 1:1024 dilution. Chest x-ray examination confirmed bilateral pleural effusions.
Paracentesis of the abdomen showed milky fluid with 45 g/l of protein, cholesterol and triglyceride levels consistent with that of chylous ascites. The ascitic fluid was negative on culture for acid-alcohol fast bacilli and other bacteria; cytology of the fluid showed no malignant cells and there was a heterogenous poptilation of lymphoid and plasma cells. Ultrasound examination of the abdomen on two occasions and an abdominal computed tomography scan did not reveal any intra-abdominal pathology other than the ascites.
Her existing treatment with frusemide and spironolactone failed to improve the ascites and she was started on a low fat diet supplemented with medium chain triglycerides (MCT oil 50 ml/day) to avoid deficiency of essential fatty acids. The aim of this diet was to provide approximately 2500-270() KJ of energy in the form of medium chain triglycerides and to reduce the intake of long chain fatty acids. 1622
On this regime of diuretics and diet, her weight reduced by 14 kg over the next three weeks. At 12 months follow up, she had lost 23 kg in weight and her abdominal girth reduced from 123 cm to 84 cm. She felt well and there was no obvious ascites or lymphoedema of her legs. Small pleural effusions and yellow dystrophic nails persisted, however. The biochemical profile and full blood count had returned to normal.
Discussion
The underlying pathology of yellow nail syndrome is probably that of a lymphatic abnormality. Patients with yellow nail syndrome have been shown to have abnormal lymphangiograms of the lower limbs" and abnormal lymphatic histology of the pleura.' The formation of chylous ascites is probably caused by oozing of lymph from the lymphagiectatic intestinal wall."' The reason for the nail changes remains unclear.
Chylous ascites in adults usually result from intraabdominal malignancy such as lymphoma or peritoneal TB. Its occurrence in yellow nail syndrome is very rare and the first case was reported by Duhra et al"' in 1985. Their 57 year old patient had a laparotomy which revealed diffusely thickened proximal jejunum and a peroral jejunal biopsy showed features of intestinal lymphangiectasia. A peritoneovenous shunt (Le Veen) was inserted and a diet low in long chain triglycerides and supplemented with medium chain triglycerides was started. The patient was free from ascites during the following 12 months. The authors attributed the success of their treatment to the shunt.
In this case, treatment with dietary manipulation and diuretics was entirely successful. The physiological basis of this treatment is to reduce the throughput of the intestiinal lymphatic system and hence the formation of chylous ascites. Long chain triglycerides are absorbed into the lacteals while medium chain triglycerides are absorbed directly into the portal venous system. Therefore by replacing long chain triglycerides with medium chain triglycerides, the load on the abnormal lymphatic system is reduced.
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